References
- Jackson I. Thyrotropin-releasing hormone. N Engl J Med. 1982; 306: 145–55
- Mizuno K, Senda Y, Mitsuma T, . Distribution of TRH in the central nervous system, its localization in the nerve cell, and the effect of various amines given to ice: immunofluorescence techniques. TRH & Spinocerebellar Degeneration, I Sobue, et al. Elsevier, New York 1986; 17–24
- Breese G R, Cott J M, Cooper A J, et al. Effects of thyrotropin-releasing hormone (TRH) on the actions of pentobarbital and other centrally acting drugs. J Pharmacol. 1975; 193: 11–22
- Horita A, Carino M A, Chesnut R M. Influence of thyrotropin releasing hormone (TRH) on druginduced narcosis and hypothermia in rabbits. Psychopharmacology. 1976; 49: 57–62
- Ishii M, Igarashi M. Effect of thyrotropin-releasing hormone on vestibular compensation in primates. Am J Otolaryngol. 1986; 7: 177–80
- Sobue I, Yamamoto H, Konagaya M, et al. Effects of thyrotropin-releasing hormone on ataxia of spinocerebellar degeneration. Lancet 1980; i: 418–19
- Ito M, Nishimaru N, Yamamoto M. Specific patterns of neuronal connections involved in the control of the rabbit's vestibulo-ocular reflexes by the cerebellar flocculus. J Physiol. 1977; 265: 833–54
- Ito M. The cerebellum and neural control. Raven Press, New York 1984
- Fukuda N, Nishimura O, Shikata M, et al. Synthesis and pharmacology of TRH analogs to separate central nervous action from endocrine activity. Chem Pharm Bull. 1980; 28: 1667–72
- Paige G. Vestibuloocular reflex and its interactions with visual following mechanisms in the squirrel monkey I. Response characteristics in normal animals. J Neurophysiol. 1983; 49: 134–51
- Adachi K, Sobue I, Tohyama M, et al. Effect of thyrotropin releasing hormone on ataxic gait in Rolling mouse Nagoya. Igaku no Ayumi (Tokyo) 1977; 101: 74–75
- Adachi K, Sobue I, Tohyama M, et al. Changes in the cerebellar noradrenaline nerve terminals of the neurological murine mutant Rolling mouse Nagoya: A histofluorescence analysis IRCS medical science: Anatomy and Human Biology;. Neurobiology and Neurophysiology 1975; 3: 329
- Keller H H, Bartholini G, Pletscher A. Enhancement of cerebral noradrenaline turnover by thyrotropin-releasing hormone. Nature 1974; 248: 528
- Horst W D, Spirt N. A possible mechanism for the anti-depressant activity of thyrotropin-releasing hormone. Life Sci 1975; 15: 1073
- Bloom F E, Hoffer B J, Siggins G B. Studies on norepinephrine-containing afferents to Purkinje cells of rat cerebellum I. Localization of the fibers and their synapse. Brain Res 1975; 93: 253–66
- Niijima K, Toshida M, Shimazu N, et al. Effect of oral administration of TRH-T on the patients with spinocerebellar degeneration. Annual Report of the Research Committee of Therapeutic Agents for Spinocerebellar Degenerations, 1979. The Ministry of Health and Welfare of Japan 1980; 275–79
- Nagawa Y, Kurihara E, Gomaibashi K, . Effect of TRH-T and DN-1417 on ataxic gait and cerebellar Cyclic AMP content in cytosine arabinoside treatment rats. Annual Report of Research Group on Treatment of Spinocerebellar Degeneration, I. Sobue, et al. Nagoya Univ., Nagoya 1982; 157–60
- Tatsuoka Y, Kato Y, Kato Y, Imuka H. Effect of DN-1417, a synthetic thyrotropin-releasing hormone analogue, on [3H]GABA binding in the cerebellum of ataxic rats. Neurosci Lett 1985; 53: 63–68
- Mailman R B, Fryer G P, et al. Changes in brain guanosine 3′,5′-monophosphate (c-GMP) content by thyrotropin releasing hormone. J Pharmacol Exp Ther 1979; 208: 169–75
- Yoshida M, Niijima K, Nagatsuka Y, . Effect of TRH and DN-1417 on cerebellar neurons in comparison with those on basal ganglia. TRH and Spinocerebellar Degeneration, I Sobue, et al. Elsevier, New York 1986; 97–103